Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases

Gynecologic Oncology

Volumn 92, Issue 1, 2004, Pages 47-56

  Sato, Takashi ^a   Sakai, Takeaki ^a   Noguchi, Yutaka ^a   Takita, Morichika ^a   Hirakawa, Shun ^b   Ito, Akira ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical carcinoma cells; MMP; TIMP; Tumor invasion; Tumor stromal cell contact

Indexed keywords

COLLAGENASE; ENZYME PRECURSOR; GELATINASE; GELATINASE A; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MEMBRANE-TYPE 1 MATRIX METALLOPROTEINASE; MESSENGER RNA; METALLOPROTEINASE; PROGELATINASE; PROSTROMELYSIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE PROCOLLAGENASE;

ARTICLE; BIOSYNTHESIS; CANCER INVASION; CELL COMMUNICATION; CELL CONTACT; COCULTURE; CONTROLLED STUDY; CYTOLOGY; ENZYME ACTIVATION; ENZYMOLOGY; FEMALE; FIBROBLAST; GENE EXPRESSION; GENETICS; HUMAN; HUMAN CELL; METABOLISM; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR CELL LINE; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; UTERINE CERVIX TUMOR;

EID: 0742307278     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.09.012     Document Type: Article

References (44)

1. Stetler-Stevenson W.G., Aznavoorian S., Liotta L.A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9:1993;541-573.
2. Seiki M. Membrane-type matrix metalloproteinases. APMIS. 107:1999;137-143.
3. Westermarck J., Kähäri V.-M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13:1999;781-792.
4. Gray S.T., Wilkins R.J., Yun K. Interstitial collagenase gene expression in oral squamous cell carcinoma. Am. J. Pathol. 141:1992;301-306.
5. Fingleton B.M., Heppner-Goss K.J., Crawford H.C., Matrisian L.M. Matrilysin in early stage intestinal tumorigenesis. APMIS. 107:1999;102-110.
6. Benbow U., Schoenermark M.P., Mitchell T.I., Rutter J.L., Shimokawa K., Nagase H.et al. A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J. Biol. Chem. 274:1999;25371-25378.
7. Sternlicht M.D., Lochter A., Sympson C.J., Huey B., Rougier J.P., Gray J.W.et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 98:1999;137-146.
8. Sternlicht M.D., Bissell M.J., Werb Z. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene. 19:2000;1102-1113.
9. Westerlund A., Hujanen E., Puistola U., Turpeenniemi-Hujanen T. Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2). Gynecol. Oncol. 67:1997;76-82.
10. Himelstein B.P., Lee E.J., Sato H., Seiki M., Muschel R.J. Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin. Exp. Metastasis. 16:1998;169-177.
11. Bair E.L., Massey C.P., Tran N.L., Borchers A.H., Heimark R.L., Cress A.E.et al. Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts. Exp. Cell Res. 270:2001;259-267.
12. Sato T., Iwai M., Sakai T., Sato H., Seiki M., Mori Y.et al. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. Br. J. Cancer. 80:1999;1137-1143.
13. Nouvo G.J., MacConnel P.B., Simsir A., Valea F., French D.L. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res. 55:1995;267-275.
14. Garzetti G.G., Ciavattini A., Lucarini G., Goteri G., Romanini C., Biagini G. The 72-kDa metalloproteinase immunostaining in cervical carcinoma: relationship with lymph nodal involvement. Gynecol. Oncol. 60:1996;271-276.
15. Gilles C., Polette M., Piette J., Munaut C., Thompson E.W., Birembaut P.et al. High level of MT1-MMP expression is associated with invasiveness of cervical cancer cells. Int. J. Cancer. 65:1996;209-213.
16. Davidson B., Goldberg I., Kopolovic J., Lerner-Geva L., Gotlieb W.H., Ben-Baruch G.et al. MMP-2 and TIMP-2 expression correlated with poor prognosis in cervical carcinoma: a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol. Oncol. 73:1999;372-382.
17. Asha-Nair S., Karunagaran D., Nair M.B., Sudhakaran P.R. Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix. J. Cancer Res. Clin. Oncol. 129:2003;123-131.
18. Takebe N., Tsunokawa Y., Nozawa S., Terada M., Sugimura T. Conservation of E6 and E7 regions of human papillomavirus types 16 and 18 present in cervical cancers. Biochem. Biophys. Res. Commun. 143:1987;837-844.
19. Ito A., Sato T., Ojima Y., Chen L.C., Nagase H., Mori Y. Calmodulin differentially modulates the interleukin 1-induced biosynthesis of tissue inhibitor of metalloproteinases and matrix metalloproteinases in human uterine cervical fibroblasts. J. Biol. Chem. 266:1991;13598-13601.
20. Sato T., Sawaji Y., Matsui N., Sato H., Seiki M., Mori Y.et al. Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion. Biochem. Biopys. Res. Commun. 265:1999;189-193.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
22. Sato T., Koike L., Miyata Y., Hirata M., Mimaki Y., Sashida Y.et al. Inhibition of activated protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinase 1 and 9 in human fibrosarcoma HT-1080 cells. Cancer Res. 62:2002;1025-1029.
23. Ito A., Yamada M., Sato T., Sanekata K., Sato H., Seiki M.et al. Calmodulin antagonists increase the expression of membrane-type-1 matrix metalloproteinase in human uterine cervical fibroblasts. Eur. J. Biochem. 251:1998;353-358.
24. Hirata M., Sato T., Tsumagari M., Shimada A., Nakano H., Hashizume K.et al. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro. Biol. Reprod. 68:2003;1276-1281.
25. Noël A., Hajitou A., L'Hoir C., Maquoi E., Baramova E., Lewalle J.M.et al. Inhibition of stromal matrix metalloproteinases: effects on breast-tumor promotion by fibroblasts. Int. J. Cancer. 76:1998;267-273.
26. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59:1999;502-511.
27. Werb Z., Tremble P.M., Behrendtsen O., Crowley E., Damsky C.H. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol. 109:1989;877-889.
28. Riikonen T., Westermarck J., Koivisto L., Broberg A., Kähäri V.M., Heino J. Integrin α2β1 is a positive regulator of collagenase (MMP-1) and collagen α1(I) gene expression. J. Biol. Chem. 270:1995;13548-13552.
29. Cannistra S.A., Ottensmeier C., Niloff J., Orta B., DiCarlo J. Expression and function of β1 and αvβ3 integrins in ovarian cancer. Gynecol. Oncol. 58:1995;216-225.
30. Felding-Habermann B., Fransvea E., O'Toole T.E., Manzuk L., Faha B., Hensler M. Involvement of tumor cell integrin αvβ3 in hematogenous metastasis of human melanoma cells. Clin. Exp. Metastasis. 19:2002;427-436.
31. Camps J.L., Chang S.M., Hsu T.C., Freeman M.R., Hong S.J., Zhau H.E.et al. Fibroblast-mediated acceleration of human epithelial tumor grow in vivo. Proc. Natl. Acad. Sci. U. S. A. 87:1990;75-79.
32. Gregoire M., Lieubeau B. The role of fibroblasts in tumor behavior. Cancer Metastasis Rev. 14:1995;339-350.
33. Ito A., Nakajima S., Sasaguri Y., Nagase H., Mori Y. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br. J. Cancer. 71:1995;1039-1045.
34. Brew K., Dinakarpandian D., Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta. 1477:2000;267-283.
35. Kruger A., Sanchez-Sweatman O.H., Martin D.C., Fata J.E., Ho A.T., Orr F.W.et al. Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line. Oncogene. 16:1998;2419-2423.
36. Wang M., Liu Y.E., Greene J., Sheng S., Fuchs A., Rosen E.M.et al. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene. 14:1997;2767-2774.
37. Baker A.H., George S.J., Zaltsman A.B., Murphy G., Newby A.C. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br. J. Cancer. 79:1999;1347-1355.
38. Boyd R.S., Balkwill F.R. MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts. Br. J. Cancer. 80:1999;315-321.
39. Philip S., Bulbule A., Kundu G.C. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-κB-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J. Biol. Chem. 276:2001;44926-44935.
40. Ramos D.M., But M., Regezi J., Schmidt B.L., Atakilit A., Dang D.et al. Expression of integrin β6 enhances invasive behavior in oral squamous cell carcinoma. Matrix Biol. 21:2002;297-307.
41. Lochter A., Navre M., Werb Z., Bissell M.J. α1 and α2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol. Biol. Cell. 10:1999;271-282.
42. Dong Z., Nemeth J.A., Cher M.L., Palmer K.C., Bright R.C., Fridman R. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells. Int. J. Cancer. 93:2001;507-515.
43. Ellerbroek S.M., Wu Y.I., Overall C.M., Stack M.S. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J. Biol. Chem. 276:2001;24833-24842.
44. Jauliac S., Lopez-Rodriguez C., Shaw L.M., Brown L.F., Rao A., Toker A. The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat. Cell Biol. 4:2002;540-544.